Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: A randomised, double-blind, placebo controlled trial

Archives of Disease in Childhood

Volumn 95, Issue 7, 2010, Pages 540-543

  Todi, Vivek Kumar ^a   Lodha, Rakesh ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AYURVEDIC DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HOMEOPATHIC AGENT; MONTELUKAST; PLACEBO; STEROID; THEOPHYLLINE;

ADD ON THERAPY; ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMERGENCY CARE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MODIFIED PULMONARY INDEX SCORE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE;

ACETATES; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; QUINOLINES; SEVERITY OF ILLNESS INDEX;

EID: 77953787641     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.168567     Document Type: Article

References (14)

1. Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. In: Chadwick D, Cardew G, eds. The rising trends in asthma. Ciba Foundation Symposium 206. Chichester, UK: John Wiley and Sons, 1997:122-39.
2. Paramesh H. Epidemiology of asthma in India. Indian J Pediatr 2002;69:309-12.
3. Lipworth BJ. Treatment of acute asthma. Lancet 1997;350(Suppl 2):SII18-23.
4. Camargo CA Jr, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167:528-33.
5. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260-5.
6. Harmanci K, Bakirtas A, Turktas I, et al. Oral montelukast treatment of preschoolaged children with acute asthma. Ann Allergy Asthma Immunol 2006;96:731-5. (Pubitemid 43749007)
7. Nelson KA, Smith SR, Trinkaus K, et al. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years. Pediatr Emerg Care 2008;24:21-7.
8. Carroll CL, Sekaran AK, Lerer TJ, et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2005;94:355-9.
9. The British Guidelines on Asthma Management 1995. Review and position statement. Thorax 1997;52:s1-21.
10. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001;1:CD002178.
11. Scarfone RJ, Fuchs SM, Nager AL, et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92:513-18.
12. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 2006;97:98-104.
13. Reiss TF, Sorkness CA, Stricker W, et al. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997;52:45-8.
14. Bisgaard H, Skoner D, Boza ML, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009;44:568-79.